Vycor Medical (VYCO) Other Accumulated Expenses (2010 - 2025)
Vycor Medical (VYCO) reported Other Accumulated Expenses of $88429.0 for Q2 2025, down 44.69% year-over-year from $159886.0 in Q2 2024, and down 29.94% on a QoQ basis from $126212.0 in Q1 2025.
Vycor Medical (VYCO) has 15 years of Other Accumulated Expenses data on file, last reported at $88429.0 in Q2 2025.
- Quarterly Other Accumulated Expenses fell 44.69% year-over-year to $88429.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $88429.0 (down 44.69% YoY) and the FY2024 annual result came in at $157545.0, up 3.77% from the prior year.
- Other Accumulated Expenses fell to $88429.0 in Q2 2025 per VYCO's latest filing, from $126212.0 in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $2.3 million in Q3 2023 and bottomed at $88429.0 in Q2 2025.
- The 5-year median for Other Accumulated Expenses is $129937.0 (2021), against an average of $462601.2.
- The widest annual swing landed in 2023, when Other Accumulated Expenses soared 2230.12%; it then plunged 93.76% in 2024.
- Tracing VYCO's Other Accumulated Expenses over 5 years: stood at $126959.0 in 2021, then jumped by 1432.95% to $1.9 million in 2022, then slumped by 92.2% to $151816.0 in 2023, then rose by 3.77% to $157545.0 in 2024, then plunged by 43.87% to $88429.0 in 2025.
- Per Business Quant, the three latest VYCO Other Accumulated Expenses figures stand at $88429.0 (Q2 2025), $126212.0 (Q1 2025), and $157545.0 (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Vycor Medical | - | - | 375,153.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 88,429.00 |
| Mar 31, 2025 | 126,212.00 |
| Dec 31, 2024 | 157,545.00 |
| Sep 30, 2024 | 187,995.00 |
| Jun 30, 2024 | 159,886.00 |
| Mar 31, 2024 | 131,532.00 |
| Dec 31, 2023 | 151,816.00 |
| Sep 30, 2023 | 126,890.00 |
| Jun 30, 2023 | 2.11 Mn |
| Mar 31, 2023 | 2.11 Mn |
| Dec 31, 2022 | 1.95 Mn |
| Sep 30, 2022 | 97,445.00 |
| Jun 30, 2022 | 148,322.00 |
| Mar 31, 2022 | 123,937.00 |
| Dec 31, 2021 | 126,959.00 |
| Sep 30, 2021 | 123,658.00 |
| Jun 30, 2021 | 128,342.00 |
| Mar 31, 2021 | 121,441.00 |
| Dec 31, 2020 | 117,050.00 |
| Sep 30, 2020 | 116,085.00 |
| Jun 30, 2020 | 107,146.00 |
| Mar 31, 2020 | 170,060.00 |
| Dec 31, 2019 | 233,067.00 |
| Sep 30, 2019 | 267,573.00 |
| Jun 30, 2019 | 310,313.00 |
| Mar 31, 2019 | 327,760.00 |
| Dec 31, 2018 | 295,056.00 |
| Sep 30, 2018 | 305,273.00 |
| Jun 30, 2018 | 196,985.00 |
| Mar 31, 2018 | 227,696.00 |
| Dec 31, 2017 | 161,328.00 |
| Sep 30, 2017 | 195,532.00 |
| Jun 30, 2017 | 195,915.00 |
| Mar 31, 2017 | 231,127.00 |
| Dec 31, 2016 | 199,457.00 |
| Sep 30, 2014 | 67,130.00 |
| Jun 30, 2014 | 126,346.00 |
| Mar 31, 2014 | 88,804.00 |
| Dec 31, 2013 | 61,576.00 |
| Sep 30, 2013 | 67,956.00 |
| Jun 30, 2013 | 85,427.00 |
| Mar 31, 2013 | 137,938.00 |
| Dec 31, 2012 | 241,918.00 |
| Sep 30, 2012 | 238,006.00 |
| Jun 30, 2012 | 287,334.00 |
| Mar 31, 2012 | 239,855.00 |
| Dec 31, 2011 | 72,122.00 |
| Sep 30, 2011 | 101,179.00 |
| Jun 30, 2011 | 154,574.00 |
| Dec 31, 2010 | 90,881.00 |